XML 17 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The impact of the amended authoritative guidance on the Company's consolidated financial statements for the third quarter of 2012 and 2011 was as follows (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
2012
 
October 2,
2011
 
September 30,
2012
 
October 2,
2011
Cost of revenue
$
69

 
$
34

 
$
140

 
$
104

Research and development
147

 
114

 
339

 
354

Selling, general and administrative
385

 
264

 
940

 
833

Total costs and expenses
$
601

 
$
412

 
$
1,419

 
$
1,291

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following weighted average assumptions are included in the estimated fair value calculations for stock option grants:
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
2012
 
October 2,
2011
 
September 30,
2012
 
October 2,
2011
Expected term (years)
4.92


4.93

 
5.58

 
4.93

Risk-free interest rate
0.67
%
 
1.15
%
 
0.89
%
 
1.50
%
Expected volatility
65.56
%
 
60.93
%
 
62.59
%
 
59.96
%
Expected dividend yield

 

 

 

Schedule of Share-based Compensation, Activity
The following table summarizes the shares available for grant under the 2009 Plan as of September 30, 2012:
 
 
Shares
Available for Grant
 
(in thousands)
Balance at January 1, 2012
2,969

Authorized

Options granted
(429
)
Options forfeited or expired
493

RSUs granted
(2
)
RSUs forfeited or expired

Balance at September 30, 2012
3,031

Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes stock options outstanding and stock option activity under the 1999 Plan and the 2009 Plan, and the related weighted average exercise price, for the first nine months of 2012:
 
 
Number of Shares
 
Weighted
Average Exercise
Price
 
Weighted
Average
Remaining Term
 
Aggregate
Intrinsic Value
 
(in thousands)
 
 
 
(in years)
 
(in thousands)
Balance outstanding at January 1, 2012
7,483

 
$
2.58

 
 
 
 
Granted
345

 
2.76

 
 
 
 
Forfeited or expired
(493
)
 
3.60

 
 
 
 
Exercised
(353
)
 
1.87

 
 
 
 
Balance outstanding at September 30, 2012
6,982

 
$
2.56

 
6.00

 
$
3,114

Exercisable at September 30, 2012
5,017

 
$
2.53

 
5.06

 
$
2,683

Vested and expected to vest at September 30, 2012
6,669

 
$
2.55

 
5.88

 
$
3,065

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
 
RSUs Outstanding
 
Number of Shares
 
Weighted Average
Grant Date Fair Value
 
(in thousands)
 
 
Nonvested at January 1, 2012

 
$

Granted
86

 
2.19

Vested
(86
)
 
2.19

Forfeited

 

Nonvested at September 30, 2012

 
$


Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumption
The fair value of rights issued pursuant to the Company's ESPP was estimated on the commencement date of each offering period using the following weighted average assumptions:
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
2012
 
October 2,
2011
 
September 30,
2012
 
October 2,
2011
Expected term (months)
6.08

 
6.00

 
6.08

 
6.00

Risk-free interest rate
0.14
%
 
0.10
%
 
0.14
%
 
0.10
%
Volatility
67.93
%
 
47.00
%
 
67.93
%
 
47.00
%
Dividend yield